Skip header and navigation

74 records – page 1 of 4.

Date Research Question / Title Unique ID Research Team
April 4, 2020 What is the evidence for early implementation of field hospitals for COVID-19? EOC040203 RR EOC
April 7, 2020 What is the prevalence of sore throat as a symptom of COVID-19? EOC040201 RR EOC
April 11, 2020 Is the IgM or IgG immune response protective? LAB040803 RR Laboratory
April 14, 2020 What decision support or communication materials are available for helping LTC directors discuss care options with resdients' family members? LTC040801 RR Long Term Care
April 15, 2020 At what time in the disease timeline of COVID-19 do antibodies develop? LAB041402 RR Laboratory
April 15, 2020 How well does the presence and level of antibodies predict the presence or absence of the disease? LAB041401 RR Laboratory
April 17, 2020 What distinguishes COVID-19 from influenza-like illnesses? PPE041701 RR Personal Protective Equipment
April 17, 2020 How well does the presence and level of antibodies predict the clinical course of disease? LAB041501 RR Laboratory
April 27, 2020 What is the best evidence to guide the sequence or priority of re-opening each type of healthcare service and how have the closures impacted patients? EOC042202 RR EOC
April 27, 2020 What are the classification levels for disease severity of COVID-19 and how should each level be treated? EOC042201 RR EOC
April 29, 2020 How can LTC facilities prepare for a pandemic? LTC042201 RR Long Term Care
April 30, 2020 How is "compassionate visit" defined and operationalized in the context of an infectious outbreak or pandemic? LTC042402 RR Long Term Care
May 7, 2020 What are best practices for engaging family care providers during a pandemic? LTC042401 RR Long Term Care
May 8, 2020 What proportion of disease transmission is due to asymptomatic, pre-symptomatic and symptomatic cases? [Update] LAB040701v2 RR Laboratory
May 11, 2020 What percentage of COVID-19 patients have hyposmia or anosmia? EOC033102 RR EOC
May 19, 2020 What are the risk factors for severity and death associated with COVID-19? EPM050901 RR Epidemiology & Modelling
May 19, 2020 Risk estimates for clinical factors predicting severity and/ or mortality associated with COVID-19 EPM050901 RR Table Epidemiology & Modelling
May 19, 2020 What is the relationship between antibody development and viral shedding and infectiousness? [Update] LAB041601v2 RR Laboratory
May 22, 2020 In similar jurisdictions experiencing the COVID-19 pandemic, what is the proportion of patients receiving non-invasive ventilation versus those receiving intermittent mandatory ventilation? EOC052102 RR EOC
May 25, 2020 What are the fatality rates associated with COVID-19 for ICU, hospitalized, and patients discharged from ICU to general wards? EPM052101 RR Epidemiology & Modelling

74 records – page 1 of 4.